EWM
TEVA icon

Evermay Wealth Management’s Teva Pharmaceuticals TEVA Stock Holding History

Evermay Wealth Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.32K Hold
216
– – ﹤0.01% 537
2026
Q1 		$6.51K Hold
216
– – ﹤0.01% 492
2025
Q4 		$6.74K Hold
216
– – ﹤0.01% 472
2025
Q3 		$4.36K Hold
216
– – ﹤0.01% 477
2025
Q2 		$3.62K Hold
216
– – ﹤0.01% 484
2025
Q1 		$3.32K Buy
+216
New +$3.86K ﹤0.01% 499

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Evermay Wealth Management's TEVA Position: Q2 2026 in Review

Evermay Wealth Management held its Teva Pharmaceuticals (TEVA) position steady in Q2 2026 at 216 shares worth $7.32K. The position accounts for ﹤0.01% of the portfolio, ranked #537.

Evermay Wealth Management first reported a position in TEVA in Q1 2025 and has held it in 6 quarters since. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Evermay Wealth Management held 216 shares of Teva Pharmaceuticals worth $7.32K as of Q2 2026.
  • Evermay Wealth Management left its Teva Pharmaceuticals share count unchanged in Q2 2026.
  • Teva Pharmaceuticals made up ﹤0.01% of Evermay Wealth Management's portfolio in Q2 2026, its #537 holding.
  • Evermay Wealth Management first reported a position in Teva Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Evermay Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.